PEAK6 Investments’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

PEAK6 Investments’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40,033	Closed	-$30K	–	5540
2022 Q3	$30K	Buy	+40,033	New	+$25.4K	﹤0.01%	4465
2022 Q2	–	Sell	-46,633	Closed	-$8K	–	6042
2022 Q1	$8K	Hold	46,633	–	–	﹤0.01%	4864
2021 Q4	$27K	Hold	46,633	–	–	﹤0.01%	4757
2021 Q3	$31K	Hold	46,633	–	–	﹤0.01%	4724
2021 Q2	$52K	Hold	46,633	–	–	﹤0.01%	4589
2021 Q1	$42K	Buy	+46,633	New	+$78.9K	﹤0.01%	4536

PEAK6 Investments's FLACW Position: Q4 2022 in Review

PEAK6 Investments sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 40,033 shares — an estimated $30K sold.

PEAK6 Investments first reported a position in FLACW in Q1 2021 and held it in 6 quarters. The position peaked at $52K in Q2 2021. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

PEAK6 Investments reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
PEAK6 Investments sold 40,033 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $30K.
PEAK6 Investments first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
PEAK6 Investments's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $52K in Q2 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.